quinpirole has been researched along with Parkinson Disease in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (18.92) | 18.7374 |
| 1990's | 10 (27.03) | 18.2507 |
| 2000's | 14 (37.84) | 29.6817 |
| 2010's | 4 (10.81) | 24.3611 |
| 2020's | 2 (5.41) | 2.80 |
| Authors | Studies |
|---|---|
| Gmeiner, P; Hübner, H; Stanek, M; Weichert, D | 1 |
| Fazli-Tabaei, S; Khakpai, F; Zarrindast, MR | 1 |
| Chen, D; Guo, M; He, F; Jia, Q; Li, M; Li, Y; Sun, S; Sun, Y; Wang, M; Wang, X; Xiang, T; Yao, X; Zhang, X | 1 |
| Ahlers-Dannen, KE; Alberico, S; Fisher, RA; Luo, Z; Narayanan, NS; Spicer, MM; Stevens, HE; Yang, J | 1 |
| Lee, D; Wiemerslage, L | 1 |
| Ismael, S; Lee, D; Wiemerslage, L | 1 |
| Brown, P; Harnack, D; Kupsch, A; Magill, PJ; Meissner, W; Sharott, A | 1 |
| Cai, G; Friedman, E; Torres, C; Zhen, X | 1 |
| Chancellor, MB; De Groat, WC; Kuno, S; Seki, S; Yoshimura, N | 1 |
| Bernardi, G; Calabresi, P; Centonze, D; Picconi, B; Rossi, S | 1 |
| Axelrod, JD; Barghshoon, S; Chen, CK; Cheyette, BN; Ebert, J; Kovoor, A; Lester, HA; Schwarz, J; Schwarz, S; Seyffarth, P; Simon, MI | 1 |
| Agnati, L; Antonelli, T; Ferraro, L; Fuxe, K; Mazzoni, E; Tanganelli, S; Tomasini, MC | 1 |
| Feenstra, RW; Glennon, JC; Hesselink, MB; Long, SK; McCreary, AC; Reinders, JH; Ronken, E; Van Der Neut, M; Van Scharrenburg, G | 1 |
| Marvanova, M; Nichols, CD | 1 |
| Bystritsky, A; Engel, J; Goldstein, M; Lieberman, A; Mino, S; Regev, I | 1 |
| Duvoisin, RC; Gershanik, O; Heikkila, RE | 1 |
| Carey, RJ; Fornaguera, J; Huston, JP; Schwarting, RK | 1 |
| Bentlage, C; Björklund, A; Nikkhah, G; Olsson, M | 1 |
| Drukarch, B; Steinbusch, HW; Stoof, JC; Van Muiswinkel, FL | 1 |
| Bentlage, C; Björklund, A; Cunningham, MG; Nikkhah, G | 2 |
| Drukarch, B; Goosen, C; Sahadat, MC; Stoof, JC; Vermeulen, RJ; Wolters, EC | 1 |
| Ebinger, G; Michotte, Y; Sarre, S | 1 |
| Chase, TN; Del Dotto, P; Oh, JD | 1 |
| Féger, J; Hassani, OK | 1 |
| Andrén, PE; Ekesbo, A; Gunne, LM; Sonesson, C; Tedroff, J | 1 |
| Pèzzola, A; Popoli, P; Reggio, R | 1 |
| Ferré, S; Fuxe, K; Müller, CE; Popoli, P; Strömberg, I | 1 |
| Gulwadi, AG; Korpinen, CD; Mailman, RB; Nichols, DE; Sit, SY; Taber, MT | 1 |
| Eysel, U; Funke, K; Kerscher, N; Zhao, Y | 1 |
| Agnati, LF; Canals, M; Canela, EI; Casado, V; Ferre, S; Franco, R; Fuxe, K; Hansson, A; Hillion, J; Ibanez, CF; Lluis, C; Mallol, J; Olah, ME; Scott, R; Terasmaa, A; Torvinen, M; Watson, S; Zoli, M | 1 |
| David, JC; Graybiel, AM; Paul, ML; Robertson, HA | 1 |
| Barone, P; Braun, AR; Chase, TN | 1 |
| Heikkila, RE; Manzino, L; Sonsalla, PK | 1 |
| Jenner, P; Marsden, CD | 1 |
| Anderson, D; Gordon, J; Herbster, G; Koller, W; Wack, R | 1 |
| Bankiewicz, KS; Barone, P; Chase, TN; Corsini, GU; Kopin, IJ | 1 |
1 review(s) available for quinpirole and Parkinson Disease
| Article | Year |
|---|---|
The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine; Ergolines; Humans; Levodopa; Macaca mulatta; Neural Pathways; Pargyline; Parkinson Disease; Parkinson Disease, Secondary; Pyridines; Quinpirole; Rats; Saimiri; Selegiline; Species Specificity; Substantia Nigra | 1986 |
36 other study(ies) available for quinpirole and Parkinson Disease
| Article | Year |
|---|---|
Structure-guided development of dual β2 adrenergic/dopamine D2 receptor agonists.
Topics: Adrenergic beta-2 Receptor Agonists; Animals; Benzoxazines; CHO Cells; Cricetulus; Dopamine Agonists; Drug Discovery; HEK293 Cells; Humans; Models, Molecular; Parkinson Disease; Polypharmacology; Receptors, Adrenergic, beta-2; Receptors, Dopamine D2 | 2016 |
Synergistic effect between quinpirole and L-NAME as well as sulpiride and L-arginine on the modulation of anxiety and memory processes in the 6-OHDA mouse model of Parkinson's disease: An isobologram analysis.
Topics: Adrenergic Agents; Animals; Anxiety; Arginine; Disease Models, Animal; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Therapy, Combination; Enzyme Inhibitors; Male; Memory; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidopamine; Parkinson Disease; Quinpirole; Receptors, Dopamine D2; Sulpiride | 2021 |
Effects of intrastriatal injection of the dopamine receptor agonist SKF38393 and quinpirole on locomotor behavior in hemiparkinsonism rats.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Agonists; Locomotion; Male; Motor Activity; Parkinson Disease; Parkinsonian Disorders; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2021 |
Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
Topics: Age Factors; Age of Onset; alpha-Synuclein; Animals; Dopamine; Dopamine Agonists; Dopaminergic Neurons; Humans; Locomotion; Mice; Mice, Knockout; Parkinson Disease; Pars Compacta; Quinpirole; Receptors, Dopamine D2; RGS Proteins; Synaptic Transmission | 2019 |
Role of Drosophila calcium channel cacophony in dopaminergic neurodegeneration and neuroprotection.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Calcium Channels; Calcium Chelating Agents; Dopaminergic Neurons; Drosophila; Drosophila Proteins; Edetic Acid; Embryo, Nonmammalian; Mutation; Nerve Degeneration; Neuroprotective Agents; Parkinson Disease; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2 | 2015 |
Early alterations of mitochondrial morphology in dopaminergic neurons from Parkinson's disease-like pathology and time-dependent neuroprotection with D2 receptor activation.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Cells, Cultured; Disease Models, Animal; Dopaminergic Neurons; Drosophila melanogaster; Mitochondria; Neuroprotection; Parkinson Disease; Quinpirole; Receptors, Dopamine D2 | 2016 |
Oscillatory local field potentials recorded from the subthalamic nucleus of the alert rat.
Topics: Animals; Antiparkinson Agents; Biological Clocks; Dopamine Agonists; Dyskinesias; Female; Humans; Levodopa; Male; Membrane Potentials; Middle Aged; Motor Activity; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Reference Values; Rest; Subthalamic Nucleus; Wakefulness | 2002 |
Inhibition of protein tyrosine/mitogen-activated protein kinase phosphatase activity is associated with D2 dopamine receptor supersensitivity in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine Agonists; Oxidopamine; Parkinson Disease; PC12 Cells; Phosphorylation; Protein Tyrosine Phosphatases; Quinpirole; Rats; Receptors, Dopamine D2; Sympatholytics; Tyrosine; Vanadates | 2002 |
Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzopyrans; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Injections, Intravenous; Injections, Intraventricular; Male; Microinjections; Oxazines; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Substantia Nigra; Urinary Bladder; Urination | 2003 |
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism.
Topics: Animals; Antiparkinson Agents; Basal Ganglia; Dopamine Agonists; gamma-Aminobutyric Acid; Glutamic Acid; Levodopa; Male; Models, Animal; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D2; Synaptic Transmission | 2004 |
D2 dopamine receptors colocalize regulator of G-protein signaling 9-2 (RGS9-2) via the RGS9 DEP domain, and RGS9 knock-out mice develop dyskinesias associated with dopamine pathways.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Antagonists; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Mice; Mice, Knockout; Movement Disorders; Parkinson Disease; Patch-Clamp Techniques; Protein Interaction Mapping; Protein Structure, Tertiary; Quinpirole; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reserpine; RGS Proteins; Subcellular Fractions; Sulpiride; Transfection | 2005 |
Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.
Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adrenergic Agents; Animals; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Electrochemistry; gamma-Aminobutyric Acid; Globus Pallidus; Male; Microdialysis; Models, Biological; Oxidopamine; Parkinson Disease; Phenethylamines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2 | 2006 |
In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Topics: Animals; Benzoxazoles; Binding, Competitive; Brain; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Interactions; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Lisuride; Male; Molecular Structure; Parkinson Disease; Piperazines; Quinpirole; Radioligand Assay; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Fusion Proteins; Serotonin 5-HT1 Receptor Agonists; Serotonin Receptor Agonists | 2006 |
Identification of neuroprotective compounds of caenorhabditis elegans dopaminergic neurons against 6-OHDA.
Topics: Animals; Bromocriptine; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cell Line; Dopamine; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Humans; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Quinpirole | 2007 |
Therapeutic potentials of centrally acting dopamine and alpha 2-adrenoreceptor agonists.
Topics: Adrenergic alpha-Agonists; Animals; Dopamine; Ergolines; Haplorhini; Humans; Neurons; Norepinephrine; Parkinson Disease; Pergolide; Quinpirole; Rats | 1983 |
Behavioral correlations of dopamine receptor activation.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Disease Models, Animal; Ergolines; Female; Locomotion; Mice; Mice, Inbred Strains; Parkinson Disease; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reserpine | 1983 |
Stimulation of D1- or D2-receptors in drug-naive rats with different degrees of unilateral nigro-striatal dopamine lesions.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Dopamine; Ergolines; Locomotion; Male; Nerve Degeneration; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Time Factors | 1995 |
Forelimb akinesia in the rat Parkinson model: differential effects of dopamine agonists and nigral transplants as assessed by a new stepping test.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analysis of Variance; Animals; Apomorphine; Brain Tissue Transplantation; Carbidopa; Dextroamphetamine; Disease Models, Animal; Dopamine; Dopamine Agonists; Ergolines; Female; Fetal Tissue Transplantation; Forelimb; Functional Laterality; Levodopa; Motor Activity; Movement Disorders; Norepinephrine; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Rotation; Substantia Nigra; Transplantation, Heterotopic | 1995 |
Dopamine D-2 autoreceptors regulating the release of dopamine from cultured rat fetal dopaminergic neurons do not desensitize upon sustained activation: implications for the combined pharmaco- and grafting therapy in parkinsonian patients.
Topics: Animals; Atropine; Brain Tissue Transplantation; Carbachol; Cells, Cultured; Dopamine; Dopamine Agents; Ergolines; Fetal Tissue Transplantation; Fetus; Mesencephalon; Neurons; Parkinson Disease; Potassium; Quinpirole; Rats; Receptors, Dopamine D2; Receptors, Muscarinic | 1994 |
Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Behavior, Animal; Dopamine; Dopamine Agents; Ergolines; Female; Fetal Tissue Transplantation; Graft Survival; Mesencephalon; Neurons; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Rotation; Stereotyped Behavior; Substantia Nigra | 1994 |
The selective dopamine D1 receptor agonist, SKF 81297, stimulates motor behaviour of MPTP-lesioned monkeys.
Topics: Analysis of Variance; Animals; Benzazepines; Disease Models, Animal; Dopamine Agents; Ergolines; Macaca mulatta; Male; Motor Activity; MPTP Poisoning; Parkinson Disease; Quinpirole; Remoxipride | 1993 |
Levodopa biotransformation in hemi-Parkinson rats: effect of dopamine receptor agonists and antagonists.
Topics: Animals; Antiparkinson Agents; Benzazepines; Biotransformation; Corpus Striatum; Denervation; Dopamine Agonists; Dopamine Antagonists; Levodopa; Male; Parkinson Disease; Quinpirole; Rats; Rats, Wistar; Sulpiride | 1996 |
Protein kinase A inhibitor attenuates levodopa-induced motor response alterations in the hemi-parkinsonian rat.
Topics: Animals; Antiparkinson Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dopamine Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme Inhibitors; Levodopa; Male; Motor Activity; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Stereotyped Behavior; Thionucleotides | 1997 |
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Topics: Adrenergic Agents; Animals; Apomorphine; Benzazepines; Dopamine Agonists; Male; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Substantia Nigra; Thalamic Nuclei | 1999 |
Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
Topics: Age Factors; Animals; Animals, Newborn; Behavior, Animal; Brain Tissue Transplantation; Corpus Striatum; Dopamine; Dopamine Agonists; Fetal Tissue Transplantation; Fluorescent Dyes; Graft Survival; Nerve Fibers; Neural Pathways; Neurons; Oxidopamine; Parkinson Disease; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Rotation; Stilbamidines; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1999 |
Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions.
Topics: Adamantane; Animals; Apomorphine; Benzazepines; Benzopyrans; Callithrix; Dopamine Antagonists; Dose-Response Relationship, Drug; Female; Levodopa; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Quinpirole; Rotation | 2000 |
Effects of SCH 58261, an adenosine A(2A) receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats. Lack of tolerance after chronic caffeine intake.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Behavior, Animal; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Male; Motor Activity; Neuroprotective Agents; Parkinson Disease; Purinergic P1 Receptor Antagonists; Pyrimidines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Time Factors; Triazoles | 2000 |
Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum.
Topics: Adenosine; Animals; Corpus Striatum; Denervation; Disease Models, Animal; Dopamine; Functional Laterality; Humans; Male; Oxidopamine; Parkinson Disease; Phenethylamines; Purinergic P1 Receptor Antagonists; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Reference Values | 2000 |
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Hydroxydopamines; Isoquinolines; Male; Naphthols; Neostriatum; Parkinson Disease; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Stereotyped Behavior; Sympathectomy, Chemical | 2001 |
Changes of contrast gain in cat dorsal lateral geniculate nucleus by dopamine receptor agonists.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Cats; Contrast Sensitivity; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Geniculate Bodies; Male; Neural Inhibition; Neurons; Parkinson Disease; Photic Stimulation; Quinpirole; Receptors, Dopamine; Synaptic Transmission; Vision Disorders; Visual Pathways | 2001 |
Coaggregation, cointernalization, and codesensitization of adenosine A2A receptors and dopamine D2 receptors.
Topics: Animals; Cells, Cultured; Cyclic AMP; Fluorescent Antibody Technique; Humans; Mice; Microscopy, Confocal; Parkinson Disease; Protein Binding; Protein Conformation; Quinpirole; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Dopamine D2; Receptors, Purinergic P1; Tumor Cells, Cultured | 2002 |
D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amino Acid Sequence; Animals; Behavior, Animal; Benzazepines; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Agents; Ergolines; Male; Molecular Sequence Data; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Quinpirole; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1992 |
D-1/D-2 dopamine receptor interactions in the regulation of extrapyramidal motor function: studies in animal models and parkinsonian patients.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Ergolines; Humans; Motor Activity; Parkinson Disease; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2 | 1986 |
Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Basal Ganglia; Benzazepines; Corpus Striatum; Denervation; Dextroamphetamine; Ergolines; Female; Flunarizine; Functional Laterality; Haloperidol; Levodopa; Neural Pathways; Parkinson Disease; Quinpirole; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Substantia Nigra | 1988 |
Quinpirole hydrochloride, a potential anti-parkinsonism drug.
Topics: Animals; Benzazepines; Corpus Striatum; Dogs; Dose-Response Relationship, Drug; Ergolines; Grooming; Haloperidol; Male; Motor Activity; Parkinson Disease; Quinpirole; Rats; Rats, Inbred Strains; Spiperone; Stereotyped Behavior; Sulpiride | 1987 |
Dopaminergic mechanisms in hemiparkinsonian monkeys.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Benzazepines; Biomechanical Phenomena; Dopamine; Dose-Response Relationship, Drug; Ergolines; Female; Macaca fascicularis; Male; Movement Disorders; Parkinson Disease; Quinpirole; Rotation | 1987 |